1 1

DATAR

TruCheck

TruCheck

Log in to see the price
Test type
View full details

Early Cancer Screening

https://www.datarpgx.de/trucheck/

TruCheck™ is a new blood-based paradigm in multicancer detection. It is used in one of two forms: 

  • Trucheck™ Intelli (screening up to 70 solid tumours)
  • Trucheck™ FemmeSafe (screening for Breast, Ovaries, Uterus, Cervix)

About TruCheck™

About 4.4 million new cancers are detected every year in Europe as well as about 2 million cancer-related deaths. Unfortunately, cancers are often only detected at an advanced stage which necessitate more intensive and expensive treatments that have greater risk of side effects. Detection of cancers at early / local stages can be vital for successful treatment. TruCheck™ is the culmination of years of collaborative international research and innovation and has been developed, tested, and validated on > 40.000 individuals.

TruCheck™ technology

  • TruCheck™ detects circulating tumour cells (CTCs) which are released by malignant tumours, but not from non-cancerous (normal / benign tumour / inflammatory) tissue. Hence CTCs are ubiquitously seen in the blood of cancer patients but almost absent in the blood of healthy individuals.
  • TruCheck™ Intelli can distinguish ~70 types of solid tumours which account for ~81% of all cancer cases and ~84% of all cancer-related deaths in Europe.
  • In clinical studies, TruCheck™ has a sensitivity of 88% in the detection of cancer at all stages and types.
  • Real-world data has shown a sensitivity, depending on the tumor, of 65% - 89% and a specificity of 96% - 99%.

TruCheck™ is particularly recommended for ...

  • Asymptomatic individuals who have a family history of cancer
  • Individuals who want to include this test in their yearly check-up
  • Asymptomatic individuals who have a high risk of cancer

Advantages

In contrast to screening for a single cancer at a time, TruCheckTM can identify multiple cancer types via a simple blood draw that may be undetectable by present technologies. Detection at earlier stages is associated with greater rates of successful treatment and improved survival.

TruCheckTM Intelli interrogates CTCs for the molecular imprint of the tumour mass from where the CTCs originated, i.e., TrucheckTM Intelli reveals diagnostically relevant information about the tissue / organ of origin of the tumor with high accuracy. This guides further investigations and reduces diagnostic trial and error.

TrucheckTM is an advanced comprehensive cancer detection that offers an unparalleled combination of sensitivity and specificity for early detection of cancers in asymptomatic individuals.

Sample collection

Requirements: Total 3 tubes containing 30 ml whole blood

Blood draw: 3 EDTA tubes, each 10 ml

Note: Blood draw should be performed only by qualified medical personnel. Ship at +2 °C to +6 °C in the container provided by DCG.

Precautions

  • Blood samples must be collected following a 6-hour fasting period. Consumption of fluids is permitted.
  • All 4 pages of the Test Request Form (TRF) are to be read and completed by the patient and the doctor. 

Certifications/accreditations of Datar Cancer Genetics

Certifications of Datar Cancer Genetics